VIJ.F VIEMED HLTHCARE INC. O.N.
- Market cap
- EUR 307M
- P/E
- 24.5x
- P/B
- 2.28x
- ROE
- 8.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is VIJ.F undervalued?
Graham numberVIJ.F trades 57.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
VIEMED HLTHCARE INC. O.N. fundamental analysis
No fundamental analysis for VIEMED HLTHCARE INC. O.N. yet.
VIEMED HLTHCARE INC. O.N. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About VIEMED HLTHCARE INC. O.N.
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. …
Full company profileVIEMED HLTHCARE INC. O.N. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
VIEMED HLTHCARE INC. O.N. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 117M | 139M | 183M | 224M | 270M | 312M |
| Gross Profit | 73.4M | 84.7M | 113M | 133M | 155M | 179M |
| Operating Income | 12.0M | 8.60M | 15.0M | 16.0M | 20.7M | 22.8M |
| EBITDA | - | 24.8M | 36.7M | 42.3M | 51.6M | 72.4M |
| Net Income | 9.13M | 6.22M | 10.2M | 11.3M | 14.9M | 13.3M |
| EPS | 0.23 | 0.16 | 0.27 | 0.29 | 0.39 | 0.35 |
| Balance Sheet | ||||||
| Total Assets | 118M | 117M | 155M | 177M | 199M | 208M |
| Total Liabilities | 23.1M | 19.9M | 41.0M | 43.8M | 55.6M | 55.6M |
| Shareholders' Equity | 94.8M | 97.1M | 114M | 131M | 142M | 150M |
| Cash & Short-term Investments | 28.4M | 16.9M | 12.8M | 17.5M | 13.5M | 9.68M |
| Cash Flow | ||||||
| Operating Cash Flow | 22.5M | 27.7M | 45.2M | 39.1M | 51.9M | 79.2M |
| Capital Expenditure | 19.7M | 22.9M | 26.1M | 37.8M | 40.0M | 51.9M |
| Free Cash Flow | 2.75M | 4.85M | 19.1M | 1.32M | 11.9M | 27.3M |
| Ratios | ||||||
| ROE | 9.6% | 6.4% | 9.0% | 8.6% | 10.6% | 8.9% |
| ROA | 7.7% | 5.3% | 6.6% | 6.4% | 7.5% | 6.4% |
| Net Profit Margin | 7.8% | 4.5% | 5.6% | 5.0% | 5.5% | 4.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
VIEMED HLTHCARE INC. O.N. dividends
VIEMED HLTHCARE INC. O.N. has not paid dividends in the last 5 fiscal years.
Who owns VIEMED HLTHCARE INC. O.N.
- Insiders 14.00%
- Institutions 72.90%
- Public & others 13.10%
- Shares outstanding 37.9M
- Free float 30.4M
VIEMED HLTHCARE INC. O.N. company profile
- Company name
- VIEMED HLTHCARE INC. O.N.
- Ticker
- VIJ.F
- ISIN
- CA92663R1055
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,490
- Fiscal year end
- December
- Address
- 625 East Kaliste Saloom Road, Lafayette, LA, United States, 70508
- Phone
- 337 504 3802
- Website
- viemed.com
About VIEMED HLTHCARE INC. O.N.
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
VIEMED HLTHCARE INC. O.N. management
8- Mr. Casey HoytCEO & Director · born 1977
- Mr. Michael B. Moore CRTPresident · born 1977
- Mr. Trae Paul FitzgeraldChief Financial Officer · born 1988
- Mr. William Todd ZehnderCOO & Director · born 1975
- Mr. Jeremy TrahanExecutive VP, General Counsel & Corporate Secretary · born 1970
- Dr. William Dana Frazier M.D.Chief Medical Officer & Director · born 1958
- Mr. Jerome Richard Cambre IIVice President of Sales · born 1971
- Mr. Michael FreemanChief Business Development Officer